Remote Triggered Release of Doxorubicin in Tumors by Synergistic Application of Thermosensitive Liposomes and Gold Nanorods
- 19 May 2011
- journal article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 5 (6), 4919-4926
- https://doi.org/10.1021/nn201010q
Abstract
Delivery of chemotherapeutic agents after encapsulation in nanocarriers such as liposomes diminishes side-effects, as PEGylated nanocarrier pharmacokinetics decrease dosing to healthy tissues and accumulate in tumors due to the enhanced permeability and retention effect. Once in the tumor, however, dosing of the chemotherapeutic to tumor cells is limited potentially by the rate of release from the carriers and the size-constrained, poor diffusivity of nanocarriers in tumor interstitium. Here, we report the design and fabrication of a thermosensitive liposomal nanocarrier that maintains its encapsulation stability with a high concentration of doxorubicin payload, thereby minimizing “leak” and attendant toxicity. When used synergistically with PEGylated gold nanorods and near-infrared stimulation, remote triggered release of doxorubicin from thermosensitive liposomes was achieved in a mouse tumor model of human glioblastoma (U87), resulting in a significant increase in efficacy when compared to nontriggered or nonthermosensitive PEGylated liposomes. This enhancement in efficacy is attributed to increase in tumor-site apoptosis, as was evident from noninvasive apoptosis imaging using Annexin-Vivo 750 probe. This strategy affords remotely triggered control of tumor dosing of nanocarrier-encapsulated doxorubicin without sacrificing the ability to differentially dose drugs to tumors via the enhanced permeation and retention effect.Keywords
This publication has 37 references indexed in Scilit:
- Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug releaseProgress in Lipid Research, 2005
- Secreted phospholipase A2 as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissueBiochimica et Biophysica Acta (BBA) - Biomembranes, 2002
- Enzyme-activated targeting of liposomesAdvanced Drug Delivery Reviews, 2001
- The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targetingAdvances in Enzyme Regulation, 2001
- Visible-Light-Stimulated Destabilization of PEG-LiposomesMacromolecules, 2000
- Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJournal of Controlled Release, 2000
- Cascade Liposomal Triggering: Light-Induced Ca2+ Release from Diplasmenylcholine Liposomes Triggers PLA2-Catalyzed Hydrolysis and Contents Leakage from DPPC LiposomesBioconjugate Chemistry, 1998
- Sterically stabilized liposomesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1992
- pH-sensitive liposomes: acid-induced liposome fusion.Proceedings of the National Academy of Sciences of the United States of America, 1984
- p H-Sensitive Liposomes: Possible Clinical ImplicationsScience, 1980